{
  "kind": "explainer",
  "discoverable": true,
  "related": [
    {
      "slug": "vaccines",
      "label": "Vaccines overall",
      "reason": "See other disease-prevention examples."
    },
    {
      "slug": "vaccine-ingredients",
      "label": "Vaccine ingredients",
      "reason": "Product-specific safety evidence."
    },
    {
      "slug": "covid-pregnancy",
      "label": "COVID fertility and pregnancy",
      "reason": "A different vaccine with separate evidence."
    }
  ],
  "id": "hpv-vaccines-fertility-cancer",
  "slug": "hpv-vaccines",
  "title": "HPV vaccines prevent cancer",
  "summary": "HPV vaccines prevent infections that can lead to cervical cancer. Large studies and reviews have found no increased infertility risk. Protection is strongest before HPV exposure. Serious side effects are rare, and vaccination does not replace cervical screening.",
  "keyPoints": [
    {
      "text": "A major review found about 80% lower cervical-cancer incidence among people vaccinated by age 16.",
      "sources": [
        1
      ]
    },
    {
      "text": "Reviews have found no increased risk of infertility or premature ovarian failure.",
      "sources": [
        1
      ]
    },
    {
      "text": "The vaccine works best before exposure to HPV.",
      "sources": [
        1,
        3
      ]
    }
  ],
  "evidence": [
    {
      "id": "cancer-prevention",
      "heading": "Cancer prevention is visible in long-term data",
      "text": "A 2025 Cochrane review found about 80% lower cervical-cancer incidence for vaccination at or before age 16, with moderate-certainty evidence. This is a relative reduction compared with unvaccinated people, not complete protection. It is not an effect size for every HPV-associated cancer.",
      "sources": [
        1
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-h1"
      ]
    },
    {
      "id": "fertility",
      "heading": "The infertility claim has been tested",
      "text": "The review found no increased infertility risk, with moderate-certainty evidence. A Danish cohort of 996,300 girls and women recorded 144 ovarian-insufficiency diagnoses; its adjusted hazard ratio was 0.96, with a 95% confidence interval of 0.55–1.68. That study alone cannot rule out a meaningful increase in this rare outcome. The whole review’s participant total is not the fertility sample.",
      "sources": [
        1,
        2
      ],
      "detailTopics": [
        "covid-pregnancy"
      ],
      "sourceIds": [
        "vaccine-update-h1",
        "vaccine-update-h2"
      ]
    },
    {
      "id": "before-exposure",
      "heading": "Protection works best before infection",
      "text": "Vaccination prevents new HPV infections; it does not treat an established infection. Offering protection early says nothing about a child’s current sexual activity. The aim is to protect before exposure.",
      "sources": [
        1,
        3
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-h1",
        "vaccine-update-h6"
      ]
    },
    {
      "id": "hpv-safety",
      "heading": "Safety and side effects",
      "text": "Pain and short-lived symptoms are common. Fainting can lead to injury, and severe allergy is very rare. Clinical precautions and schedules depend on the product and country.",
      "sources": [
        4
      ],
      "detailTopics": [
        "vaccine-ingredients"
      ],
      "quickLink": "Safety and side effects",
      "sourceIds": [
        "vaccine-update-h5"
      ]
    },
    {
      "id": "screening",
      "heading": "Vaccination and screening do different jobs",
      "text": "Vaccination does not eliminate all future cervical-cancer risk or replace screening. Follow the official screening guidance for your country and circumstances.",
      "sources": [
        3
      ],
      "detailTopics": [],
      "sourceIds": [
        "vaccine-update-h6"
      ]
    }
  ],
  "sources": [
    {
      "id": "vaccine-update-h1",
      "title": "What are the benefits and risks of different human papillomavirus (HPV) vaccines for preventing cervical cancer and other HPV-related disease?",
      "publisher": "Cochrane, 2025",
      "url": "https://www.cochrane.org/evidence/CD015363_what-are-benefits-and-risks-different-human-papillomavirus-hpv-vaccines-preventing-cervical-cancer",
      "readerBlurb": "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction.",
      "limit": "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction."
      },
      "publicationTitle": "What are the benefits and risks of different human papillomavirus (HPV) vaccines for preventing cervical cancer and other HPV-related disease?",
      "archiveDate": "2026-10-14",
      "supports": [
        "Cancer prevention is visible in long-term data",
        "The infertility claim has been tested",
        "Protection works best before infection"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction."
      ],
      "limitationsPublic": [
        "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction."
      ]
    },
    {
      "id": "vaccine-update-h2",
      "title": "Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort",
      "publisher": "JAMA Network Open, 2021",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783512",
      "readerBlurb": "996,300 girls and women, with 144 diagnoses; the wide confidence interval leaves uncertainty for this rare outcome.",
      "limit": "996,300 girls and women, with 144 diagnoses; the wide confidence interval leaves uncertainty for this rare outcome.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "996,300 girls and women, with 144 diagnoses; the wide confidence interval leaves uncertainty for this rare outcome."
      },
      "publicationTitle": "Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort",
      "archiveDate": "2026-10-14",
      "supports": [
        "The infertility claim has been tested"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "996,300 girls and women, with 144 diagnoses; the wide confidence interval leaves uncertainty for this rare outcome."
      ],
      "limitationsPublic": [
        "996,300 girls and women, with 144 diagnoses; the wide confidence interval leaves uncertainty for this rare outcome."
      ]
    },
    {
      "id": "vaccine-update-h6",
      "title": "GARDASIL 9 — Prescribing Information",
      "publisher": "FDA",
      "url": "https://www.fda.gov/media/90064/download",
      "readerBlurb": "Prevention does not treat established infection or replace cervical screening.",
      "limit": "Prevention does not treat established infection or replace cervical screening.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Prevention does not treat established infection or replace cervical screening."
      },
      "publicationTitle": "GARDASIL 9 — Prescribing Information",
      "archiveDate": "2026-10-14",
      "supports": [
        "Protection works best before infection",
        "Vaccination and screening do different jobs"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Prevention does not treat established infection or replace cervical screening."
      ],
      "limitationsPublic": [
        "Prevention does not treat established infection or replace cervical screening."
      ]
    },
    {
      "id": "vaccine-update-h5",
      "title": "Human Papillomavirus (HPV) Vaccine Safety",
      "publisher": "CDC",
      "url": "https://www.cdc.gov/vaccine-safety/vaccines/hpv.html",
      "readerBlurb": "Describes common reactions, fainting and rare severe allergy.",
      "limit": "Describes common reactions, fainting and rare severe allergy.",
      "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
      "revision": "research-2026-10-15",
      "retrievedAt": "2026-10-14",
      "locale": "en",
      "type": "Evidence source",
      "geographicCoverage": {
        "kind": "undetermined",
        "countryCodes": [],
        "jurisdictionCodes": [],
        "note": "Describes common reactions, fainting and rare severe allergy."
      },
      "publicationTitle": "Human Papillomavirus (HPV) Vaccine Safety",
      "archiveDate": "2026-10-14",
      "supports": [
        "Safety and side effects"
      ],
      "limitationsInternal": [
        "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.",
        "Describes common reactions, fainting and rare severe allergy."
      ],
      "limitationsPublic": [
        "Describes common reactions, fainting and rare severe allergy."
      ]
    }
  ],
  "dossier": "vaccine-narratives-major-2026-10-14.md",
  "limits": [
    "The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance."
  ],
  "scope": "",
  "takeaway": "HPV vaccines prevent infections that can lead to cervical cancer.",
  "contextTitle": "",
  "contextIntro": "",
  "detail": "",
  "revision": "vaccine-2026-10-15",
  "researchDate": "2026-10-14",
  "copyReviewedAt": "2026-10-15",
  "locale": "en",
  "topic": "Vaccines",
  "tag": "HPV & fertility",
  "assessment": "Source-grounded explanation · research draft",
  "geographicScope": {
    "kind": "global",
    "countryCodes": [],
    "jurisdictionCodes": [],
    "note": "Evidence and jurisdiction limits are stated beside the relevant claims."
  },
  "reviewNeeds": "Independent clinical/editorial approval remains pending; no personalized schedule.",
  "updateTriggers": "New studies, corrected sources, regulatory safety signals and changed local recommendations.",
  "readerCopyEdition": "vaccine-clarity-2026-10-15",
  "questions": [],
  "questionsHeading": "Find the answer you need",
  "headline": {
    "text": "HPV vaccines prevent cancer",
    "revision": 1,
    "status": "draft",
    "sourceMessageId": null,
    "approvedAt": null,
    "authority": "15 October 2026 authorized vaccine implementation; source-mapped editorial brief. Agent review is not clinical or owner approval."
  },
  "language": "en",
  "jurisdiction": {
    "kind": "global",
    "countryCodes": [],
    "jurisdictionCodes": [],
    "note": "Evidence and jurisdiction limits are stated beside the relevant claims."
  },
  "claimScope": "",
  "research": {
    "dossierRef": "docs/research/vaccine-narratives-major-2026-10-14.md",
    "reviewedAt": "2026-10-14",
    "reviewDue": "New studies, corrected sources, regulatory safety signals and changed local recommendations.",
    "contraryEvidenceConsidered": [],
    "status": "research draft; editorial/context review separate"
  },
  "status": "researched draft preview",
  "realWorldClaimReviewed": false,
  "clinicalEditorialApproved": false
}